RPS responds to NICE Guideline on Atrial Fibrillation

Responding to new guidance from NICE on how best to treat people at serious risk of a stroke because of an abnormal heart rhythm, known as atrial fibrillation (AF), Helen Williams, Consultant Pharmacist and RPS spokesperson on ca
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news